相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Scientific and policy challenges to development of an AIDS vaccine
Seth Franklin Berkley et al.
LANCET (2007)
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay
Sheri Dubey et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men
Alethea W. McCormick et al.
CLINICAL INFECTIOUS DISEASES (2007)
HIV epidemiology update and transmission factors: Risks and risk contexts - 16th International AIDS Conference Epidemiology Plenary
Chris Beyrer
CLINICAL INFECTIOUS DISEASES (2007)
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
Ronald H. Gray et al.
LANCET (2007)
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: Effect of using an optimized process for isolating PBMC
Lisa S. Kierstead et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
Tong-Ming Fu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
Andrew T. Catanzaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A multicenter adolescent medicine trials network for HIV/AIDS interventions study
Rolando M. Viani et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance
Hong-Ha M. Truong et al.
AIDS (2006)
HIV vaccines: New frontiers in vaccine development
Ann Duerr et al.
CLINICAL INFECTIOUS DISEASES (2006)
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
Nancy A. Wilson et al.
JOURNAL OF VIROLOGY (2006)
Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-Infected individuals from Botswana and Cameroon
SB Gupta et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
High-dose recombinant canarypox vaccine expressing HIV-1 protein, in seronegative human subjects
PA Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates
S Santra et al.
JOURNAL OF VIROLOGY (2005)
Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents
PM Coplan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene:: Application in epidemiologic studies and in the design of adenovector vaccines
M Aste-Amézaga et al.
HUMAN GENE THERAPY (2004)
HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire
W Jennes et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Modeling partially effective HIV vaccines in vitro
R John et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein
SI Staprans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The prevalence of antiretroviral drug resistance in the United States
DD Richman et al.
AIDS (2004)
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines
DC Montefiori et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
JW Shiver et al.
ANNUAL REVIEW OF MEDICINE (2004)
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda
RH Gray et al.
AIDS (2003)
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses
R Youil et al.
HUMAN GENE THERAPY (2003)
Intracellular staining for HIV-Specific IFN-γ production:: Statistical analyses establish reproducibility and criteria for distinguishing positive responses
WL Trigona et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys
DH Barouch et al.
JOURNAL OF VIROLOGY (2003)
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene
DR Casimiro et al.
JOURNAL OF VIROLOGY (2003)
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors
MC Sprangers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens
FB Wang et al.
HUMAN GENE THERAPY (2003)
Containment of simian immunodeficiency virus infection in vaccinated macaques:: Correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses
Z Hel et al.
JOURNAL OF IMMUNOLOGY (2002)
Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice
XP Liang et al.
VACCINE (2002)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
RR Amara et al.
VACCINE (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions
BG Harvey et al.
HUMAN GENE THERAPY (2002)
Potentiation of simian immunodeficiency virus (SIV)-speciific CD4+ and CD8+ T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen
Z Hel et al.
JOURNAL OF IMMUNOLOGY (2001)
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination
DH Barouch et al.
JOURNAL OF VIROLOGY (2001)
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers
RB Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Biological considerations in the development of a human immunodeficiency virus vaccine
N Nathanson et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
